晚期上皮性卵巢癌肿瘤细胞减灭术患者的围手术期液体状态与手术结局
该研究纳入2010年12月至2015年5月在综合癌症中心因III或IV期上皮性卵巢癌行肿瘤细胞减灭术且接受上腹部手术或结肠切除的110例患者,以围手术期体重变化作为液体状态替代指标。中位围手术期体重变化为+7.3kg,中位利尿时间为3天。多因素分析显示液体状态与手术部位感染独立相关(p=0.01)。
要点
- 围手术期液体过剩在晚期上皮性卵巢癌肿瘤细胞减灭术患者中常见。
- 中位围手术期体重变化为+7.3kg(范围-0.9kg至+35.7kg)。
- 多因素分析中液体状态与手术部位感染独立相关(p=0.01)。
核心结论
- 围手术期液体过剩在因上皮性卵巢癌行肿瘤细胞减灭术的患者中常见,且与手术部位感染独立相关。
研究设计与样本
- 回顾性识别2010年12月至2015年5月在综合癌症中心因III或IV期上皮性卵巢癌行肿瘤细胞减灭术且接受上腹部手术或结肠切除的患者,共纳入110例。
主要发现
- 中位年龄62岁,中位BMI 25.8kg/m2,74.5%为IIIC期,60例(54.5%)至少行1次肠切除。
- 术中中位给予晶体液5381mL(范围1000-17550mL)和胶体液500mL(范围0-2783mL)。
- 中位围手术期体重变化为+7.3kg(范围-0.9kg至+35.7kg),中位利尿时间为3天(范围1-17天)。
- 单因素分析中净正液体状态与计划外再手术、吻合口漏、手术部位感染及住院时间>5天相关。
- 多因素分析中液体状态与手术部位感染独立相关(p=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study is to investigate the impact of fluid status on perioperative outcomes of patients undergoing cytoreductive surgery (CRS) for advanced epithelial ovarian cancer (EOC). METHODS: Patients undergoing CRS for stage III or IV EOC at a comprehensive cancer center from 12/2010 to 05/2015 were identified. Those who underwent upper abdominal procedures or colon resections were included. Demographic, perioperative, and 30-day complication data were collected. Perioperative weight change was utilized as a surrogate for fluid status. The time to diuresis (tD) was defined as the postoperative day the patient's weight began to downtrend. RESULTS: One hundred ten patients were included. Median age was 62years and median BMI 25.8kg/m2. The majority (74.5%) were stage IIIC. At least 1 bowel resection was performed in 60 cases (54.5%). A median of 5381mL of crystalloid (range 1000-17,550mL) and 500mL of colloids (range 0-2783mL) was given intraoperatively. The median perioperative weight change was +7.3kg (range-0.9kg to +35.7kg). The median tD was 3days (range 1-17days). On univariate analysis, net positive fluid status was associated with unscheduled reoperation, anastomotic leak, surgical site infections (SSI), and length of stay >5days. On multivariate analysis, fluid status was independently associated with SSI (p=0.01). CONCLUSIONS: Perioperative fluid excess is common in patients undergoing CRS for EOC and is independently associated with SSI.
引用
- Desale MG, Tanner EJ, Sinno AK, et al. Perioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2016. PMID: 28029449. doi:10.1016/j.ygyno.2016.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。